This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

More ETFs Get Sued

NEW YORK ( TheStreet) -- New lawsuits are adding to leveraged ETF woes, putting ProShares' UltraShort MSCI Emerging Markets (EEV) and UltraShort Financials ETF (SKF) under fire. The new lawsuits, which criticize ProShares' disclosure about these ETFs, come in the wake of a lawsuit against the ProShares UltraShort Real Estate (SRS) and criticism of leveraged funds at large.

Both complaints allege similar misleading practices on the part of ETF issuer ProShares. While Direxion and Rydex also offer leveraged ETF products, ProShares is widely regarded as a pioneer in the leveraged ETF business, offering a range of sector and international leveraged funds.

The complaint against EEV, filed by U.S. firm Gilman and Pastor, notes that the fund was designed to track twice the inverse of the MSCI Emerging Markets index. From Jan. 2, 2008 to Dec. 17, 2008, the MSCI Emerging Markets index fell by 52%, while EEV fell approximately 30%. If the fund tracked twice the inverse of the index for this period, EEV should have risen 104%. (Emphasis mine.)

SKF and SRS have also deviated enormously from their perceived stated objectives, along with other popular leveraged funds like Direxion Daily Financial Bull (FAS) and Direxion Daily Financial Bear (FAZ). The reason for this deviation, the daily tracking objectives of the funds, was evidently not clear to the investors initiating the lawsuits.

It is of no surprise that these lawsuits are cropping up now, in the midst of a spate of new financial regulations for the ETF industry. FINRA reminded investors back in June that leveraged ETFs had daily tracking objectives, and were not appropriate for long-term buy-and-hold investors.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
FAS $121.47 0.00%
FAZ $12.41 0.00%
EEV $16.11 0.00%
SKF $50.23 0.00%
SRS $11.98 0.00%

Markets

DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs